Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa

被引:220
作者
van Heeckeren, A [1 ]
Walenga, R [1 ]
Konstan, MW [1 ]
Bonfield, T [1 ]
Davis, PB [1 ]
Ferkol, T [1 ]
机构
[1] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Sch Med, Div Pediat Pulmonol,Dept Pediat, Cleveland, OH 44106 USA
关键词
Pseudomonas aeruginosa; lung; cystic fibrosis; inflammation;
D O I
10.1172/JCI119828
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In cystic fibrosis (CF), defective function of the cystic fibrosis transmembrane conductance regulator (CFTR) in airway epithelial cells and submucosal glands results in chronic pulmonary infection with Pseudomonas aeruginosa. The pulmonary infection incites an intense host inflammatory response, causing progressive suppurative pulmonary disease, Mouse models of CF, however, fail to develop pulmonary disease spontaneously, We examined the effects of bronchopulmonary infection on mice homozygous for the S489X mutation of the CFTR gene using an animal model of chronic Pseudomonas endobronchial infection, Slurries of sterile agarose beads or beads containing a clinical isolate of mucoid P. aeruginosa were instilled in the right lung of normal or CF mice, The mortality of CF mice inoculated with Pseudomonas-laden beads was significantly higher than that of normal animals: 82% of infected CF mice, but only 23% of normal mice, died within 10 d of infection (P = 0.023), The concentration of inflammatory mediators, including TNF-alpha, murine macrophage inflammatory protein-2, and KC/N51, in bronchoalveolar lavage fluid in CF mice 3 d after infection and before any mortality, was markedly elevated compared with normal mice, This inflammatory response also correlated with weight loss observed in both CF and normal littermates after inoculation, Thus, this model may permit, examination of the relationship of bacterial infections, inflammation, and the cellular and genetic defects in CF.
引用
收藏
页码:2810 / 2815
页数:6
相关论文
共 50 条
  • [41] Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection
    Steinkamp, Gratiana
    Schmitt-Grohe, Sabina
    Doering, Gerd
    Staab, Doris
    Pfruender, Dietmar
    Beck, Gudrun
    Schubert, Ralf
    Zielen, Stefan
    RESPIRATORY MEDICINE, 2008, 102 (11) : 1643 - 1653
  • [42] To bead or not to bead: A review of Pseudomonas aeruginosa lung infection models for cystic fibrosis
    Reyne, Nicole
    McCarron, Alexandra
    Cmielewski, Patricia
    Parsons, David
    Donnelley, Martin
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [43] Porphyromonas, a potential predictive biomarker of Pseudomonas aeruginosa pulmonary infection in cystic fibrosis
    Keravec, Marlene
    Mounier, Jerome
    Guilloux, Charles-Antoine
    Fangous, Marie-Sarah
    Mondot, Stanislas
    Vallet, Sophie
    Gouriou, Stephanie
    Le Berre, Rozenn
    Rault, Gilles
    Ferec, Claude
    Barbier, Georges
    Lepage, Patricia
    Hery-Arnaud, Genevieve
    BMJ OPEN RESPIRATORY RESEARCH, 2019, 6 (01)
  • [44] Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients
    Ehsan, Zarmina
    Wetzel, Jacqueline Denise
    Clancy, John P.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 743 - 749
  • [45] Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis
    Elborn, J. Stuart
    Flume, Patrick A.
    Van Devanter, Donald R.
    Procaccianti, Claudio
    FUTURE MICROBIOLOGY, 2021, 16 (14) : 1087 - 1104
  • [46] The Costs of Treatment of Early and Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients
    Braccini, G.
    Festini, F.
    Boni, V.
    Neri, A. S.
    Galici, V.
    Campana, S.
    Zavataro, L.
    Trevisan, F.
    Braggion, C.
    Taccetti, G.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (02) : 188 - 192
  • [47] Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
    Nina Cramer
    Jens Klockgether
    Colin F Davenport
    Burkhard Tümmler
    Molecular and Cellular Pediatrics, 1 (Suppl 1)
  • [48] Pseudomonas aeruginosa and Children With Cystic Fibrosis COMMENT
    Sala, Marc A.
    Jain, Mane
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2529 - E2530
  • [49] Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung
    Malhotra, Sankalp
    Hayes, Don, Jr.
    Wozniak, Daniel J.
    JOURNAL OF CYSTIC FIBROSIS, 2019, 18 (06) : 796 - 803
  • [50] Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
    Malhotra, Sankalp
    Hayes, Don, Jr.
    Wozniak, Daniel J.
    CLINICAL MICROBIOLOGY REVIEWS, 2019, 32 (03)